Liminatus Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LIMN and other ETFs, options, and stocks.About LIMN
Liminatus Pharma, Inc. is a pre-clinical stage biopharmaceutical company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in Cerritos, CA.
LIMN Key Statistics
Stock Snapshot
As of today, Liminatus Pharma(LIMN) shares are valued at $3.91. The company's market cap stands at 5.25M, with a P/E ratio of -0.18.
On 2026-09-03, Liminatus Pharma(LIMN) stock traded between a low of $3.61 and a high of $3.95. Shares are currently priced at $3.91, which is +8.3% above the low and -0.9% below the high.
The Liminatus Pharma(LIMN)'s current trading volume is 14.88K, compared to an average daily volume of 50.68K.
In the last year, Liminatus Pharma(LIMN) shares hit a 52-week high of $154.50 and a 52-week low of $3.42.
In the last year, Liminatus Pharma(LIMN) shares hit a 52-week high of $154.50 and a 52-week low of $3.42.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.